Introduction. While the scientific consensus on the benefits of vaccination is unambiguous,
there is a growing proportion of the population that is skeptical about vaccination. The idea …

Multilevel factors impact HPV vaccine series initiation and completion among adolescents in
the US Synthesis of these factors is needed to inform intervention development and to direct …

Background Since 2006, many countries have implemented publicly funded human
papillomavirus (HPV) immunisation programmes. However, global estimates of the extent …

OBJECTIVES This overview aims to synthesise global evidence on factors affecting
healthcare access, and variations across low‐and middle‐income countries (LMICs) vs. high …

Human papillomavirus (HPV) has been linked to genital warts and multiple cancers affecting
both men and women. Despite college students' high risk for HPV, their vaccination rates …

Human papillomavirus (HPV) vaccination prevents cervical, head and neck, and anogenital
cancers. However, global HPV vaccine coverage falls short of global targets and has seen …

Abstract In 2007, human papillomavirus (HPV) type 16 was finally recognized as a risk
factor, besides smoking and alcohol, for oropharyngeal squamous cell carcinoma (OPSCC) …

Cervical cancer is a leading cause of morbidity and mortality in women worldwide. The
availability of prophylactic vaccines for high-risk types of human papillomavirus (HPV) …

Background Though cervical cancer is one of the leading causes of cancer-related death
globally, its incidence is nearly entirely preventable. Young people have been an …

Human papillomavirus (HPV) vaccine uptake is below that of other routine adolescent
vaccines. This is due in part to the fact that the HPV vaccine is often not routinely …